ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Tampa, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Tampa, FL, USA:

A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas

The purpose of this study is to test whether giving acalabrutinib is safe and effective in controlling relapsed central nervous system (CNS) lymphoma...

Enrolling
Central Nervous System Lymphoma
Drug: Acalabrutinib

Phase 2

UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center

Tampa, Florida, United States and 2 other locations

Locations recently updated

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...

Enrolling
Lymphoma, Non-Hodgkin
Drug: Obinutuzumab
Drug: CC-99282

Phase 1, Phase 2

Celgene
Celgene

Tampa, Florida, United States and 89 other locations

The purpose of the study is to establish the safety and efficacy of zanubrutinib in combination with rituximab for people with untreated B-cell lymphomas...

Enrolling
Marginal Zone Lymphoma
B-Cell Lymphoma
Drug: Zanubrutinib
Drug: Rituximab

Phase 2

H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute

Tampa, Florida, United States

A Phase 1/2 Study of bbT369, a dual targeting CAR T cell drug product with a gene edit, in Relapsed and/or Refractory B cell Non-Hodgkin's Lymphoma...

Active, not recruiting
Diffuse Large B Cell Lymphoma (DLBCL)
Biological: bbT369

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Tampa, Florida, United States and 3 other locations

of ALLO-501 in adults with relapsed or refractory large B-cell lymphoma or follicular lymphoma after a lymphodepletion regimen comp...

Active, not recruiting
Relapsed/Refractory Follicular Lymphoma
Relapsed/Refractory Large B Cell Lymphoma
Genetic: ALLO-501
Drug: Fludarabine

Phase 1

Allogene Therapeutics

Tampa, Florida, United States and 6 other locations

Locations recently updated

to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...

Enrolling
Lymphoma, Follicular
Drug: Golcadomide
Drug: Doxorubicin

Phase 2

Celgene
Celgene

Tampa, Florida, United States and 67 other locations

This is a multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in adult patients with relapsed or refractory FL.

Active, not recruiting
Follicular Lymphoma
Biological: tisagenlecleucel

Phase 2

Novartis
Novartis

Tampa, Florida, United States and 29 other locations

by the intravenous (IV) route to participants with solid tumors or lymphomas.The main goals of this study are to:* Find the recommended dose...

Enrolling
Hodgkin Lymphoma
Follicular Lymphoma
Combination Product: Fruquintinib
Drug: IMT-009

Phase 1, Phase 2

Immunitas Therapeutics

Sarasota, Florida, United States and 9 other locations

of this study is to characterize the safety and efficacy profile of ACP-196 (acalabrutinib) in subjects with relapsed or refractory Mantle Cell Lymphoma...

Active, not recruiting
Mantle Cell Lymphoma (MCL)
Drug: ACP-196 (acalabrutinib)

Phase 2

Acerta Pharma
Acerta Pharma

Tampa, Florida, United States and 57 other locations

This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 (docirbrutinib) in patients with CLL/SLL or B-cell NHL who have failed or...

Enrolling
Marginal Zone Lymphoma
Follicular Lymphoma
Drug: Docirbrutinib

Phase 1

Carna Biosciences

Tampa, Florida, United States and 9 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems